Dendritic cell biology evolves into clinical application

Lancet

Volumn 365, Issue 9454, 2005, Pages 102-104

  Hart, Derek N J ^a  

^a MATER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; CHEMOKINE; RECEPTOR BLOCKING AGENT; TOLL LIKE RECEPTOR;

ANTIGEN PRESENTING CELL; CELL MIGRATION; CYTOLOGY; DENDRITIC CELL; HUMAN; IMMUNE SYSTEM; INFLAMMATION; NOTE; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 11844251272     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)17717-4     Document Type: Note

References (19)

1. Medzhitov R, Janeway CA. Jr. Decoding the patterns of self and nonself by the innate immune system. Science. 296:2002;298-300
2. West MA, Wallin RP, Matthews SP, et al. Enhanced dendritic cell antigen capture via toll-like receptor-induced actin remodeling. Science. 305:2004;1153-1157
3. Burns S, Hardy SJ, Buddle J, Yong KL, Jones GE, Thrasher AJ. Maturation of DC is associated with changes in motile characteristics and adherence. Cell Motil Cytoskeleton. 57:2004;118-132
4. Merad M, Manz MG, Karsunky H, et al. Langerhans cells renew in the skin throughout life under steady-state conditions. Nat Immunol. 3:2002;1135-1141
5. Garg S, Oran A, Wajchman J, et al. Genetic tagging shows increased frequency and longevity of antigen-presenting, skin-derived dendritic cells in vivo. Nat Immunol. 4:2003;907-912
6. Miller MJ, Hejazi AS, Wei SH, Cahalan MD, Parker I. T cell repertoire scanning is promoted by dynamic dendritic cell behavior and random T cell motility in the lymph node. Proc Natl Acad Sci USA. 101:2004;998-1003
7. Kadowaki N, Ho S, Antonenko S, et al. Subsets of human dendritic cell precursors express different Toll-like receptors and respond to different microbial antigens. J Exp Med. 194:2001;863-869
8. Krug A, Luker GD, Barchet W, Leib DA, Akira S, Colonna M. Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. Blood. 103:2004;1433-1437
9. Salio M, Cella M, Vermi W, et al. Plasmacytoid dendritic cells prime IFN-γ-secreting melanoma-specific CD8 lymphocytes and are found in primary melanoma lesions. Eur J Immunol. 33:2003;1052-1062
10. Figdor CG, van Kooyk Y, Adema GJ. C-type lectin receptors on dendritic cells and Langerhans cells. Nat Rev Immunol. 2:2002;77-84
11. Bonifaz LC, Bonnyay DP, Charalambous A, et al. In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J Exp Med. 199:2004;815-824
12. Kato M, Neil TK, Fearnley DB, McLellan AD, Vuckovic S, Hart DN. Expression of multilectin receptors and comparative FITC-dextran uptake by human dendritic cells. Int Immunol. 12:2000;1511-1519
13. Delamarre L, Holcombe H, Mellman I. Presentation of exogenous antigens on major histocompatibility complex (MHC) class I and MHC class II molecules is differentially regulated during dendritic cell maturation. J Exp Med. 198:2003;111-122
14. Fehervari Z, Sakaguchi S. Control of Foxp3+ CD25+CD4+ regulatory cell activation and function by dendritic cells. Int Immunol. 16:2004;1769-1780
15. Soumelis V, Liu YJ. Human thymic stromal lymphopoietin: a novel epithelial cell-derived cytokine and a potential key player in the induction of allergic inflammation. Springer Semin Immunopathol. 25:2004;325-333
16. Jocham D, Richter A, Hoffmann L, et al. Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal-cell carcinoma after radical nephrectomy: phase III, randomised controlled trial. Lancet. 363:2004;594-599
17. Xu MQ, Suo YP, Gong JP, Zhang MM, Yan LN. Prolongation of liver allograft survival by dendritic cells modified with NF-kappaB decoy oligodeoxynucleotides. World J Gastroenterol. 10:2004;2361-2368
18. Collin M, Munster D, Clark GJ, Wang X, Dickinson AM, Hart DNJ. In vitro depletion of tissue-derived dendritic cells by CMRF-44 antibody and alemtusumab: implications for the control of graft vs host disease. Transplantation (in press).
19. Munster DJ, MacDonald KP, Kato M, Hart DJ. Human T lymphoblasts and activated dendritic cells in the allogeneic mixed leukocyte reaction are susceptible to NK cell-mediated anti-CD83-dependent cytotoxicity. Int Immunol. 16:2004;33-42